메뉴 건너뛰기




Volumn 10, Issue 4, 2011, Pages 523-537

Carbohydrate-based immune adjuvants

Author keywords

adjuvants; carbohydrate; glucan; glycomics; immunity; inulin; vaccines

Indexed keywords

ACEMANNAN; ADVAX; ALGAL GLUCAN; ALPHA GLUCAN; BACTERIUM LIPOPOLYSACCHARIDE; BETA GLUCAN; BETA GLUCAN PARTICLE; CARBOHYDRATE; CHITIN; CHITOSAN; CHOLERA VACCINE; DENDRITIC CELL VACCINE; DEXTRAN; DEXTRO MURAPALMITINE; DNA VACCINE; FRUCTAN; GLUCAN; IMIQUIMOD; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; INULIN; LENTINAN; LIPOARABINOMANNAN; MANNAN; MURAMYL DIPEPTIDE; NIOSOME; SAPONIN; SULFADIMETHOXINE; TREHALOSE 6 6 DIMYCOLATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZYMOSAN;

EID: 79955085814     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.11.30     Document Type: Review
Times cited : (141)

References (124)
  • 1
    • 7044263390 scopus 로고    scopus 로고
    • Vaccine adjuvants: Current state and future trends
    • DOI 10.1111/j.0818-9641.2004.01272.x
    • Petrovsky N, Aguilar JC. Vaccine adjuvants: current state and future trends. Immunol. Cell. Biol. 82(5), 488-496 (2004). (Pubitemid 39421058)
    • (2004) Immunology and Cell Biology , vol.82 , Issue.5 , pp. 488-496
    • Petrovsky, N.1    Aguilar, J.C.2
  • 4
    • 0343643374 scopus 로고
    • Quantitative studies in diphtheria prophylaxis; The primary response
    • pl
    • Holt LB. Quantitative studies in diphtheria prophylaxis; the primary response. Brit. J. Exp. Pathol. 30(4), 289-297, pl (1949).
    • (1949) Brit. J. Exp. Pathol. , vol.30 , Issue.4 , pp. 289-297
    • Holt, L.B.1
  • 5
    • 0001294999 scopus 로고
    • The effect of paraffin oil and mycobacteria on antibody formation and sensitization; A review
    • Freund J. The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review. Am. J. Clin. Pathol. 21(7), 645-656 (1951).
    • (1951) Am. J. Clin. Pathol. , vol.21 , Issue.7 , pp. 645-656
    • Freund, J.1
  • 6
    • 54249154153 scopus 로고    scopus 로고
    • Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: Results of a Phase I-II randomized clinical trial
    • Keitel WA, Campbell JD, Treanor JJ et al. Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a Phase I-II randomized clinical trial. J. Infect. Dis. 198(9), 1309-1316 (2008).
    • (2008) J. Infect. Dis. , vol.198 , Issue.9 , pp. 1309-1316
    • Keitel, W.A.1    Campbell, J.D.2    Treanor, J.J.3
  • 9
    • 0030457699 scopus 로고    scopus 로고
    • Adjuvant effect of DEAE-dextran and tetanus toxoid on whole cell heat inactivated phenol preserved typhoid vaccine
    • Kaistha J, Sokhey J, Singh S, Kumar S, John PC, Sharma NC. Adjuvant effect of DEAE-dextran and tetanus toxoid on whole cell heat inactivated phenol preserved typhoid vaccine. Indian J. Pathol. Microbiol. 39(4), 287-292 (1996).
    • (1996) Indian J. Pathol. Microbiol. , vol.39 , Issue.4 , pp. 287-292
    • Kaistha, J.1    Sokhey, J.2    Singh, S.3    Kumar, S.4    John, P.C.5    Sharma, N.C.6
  • 10
    • 77953264382 scopus 로고    scopus 로고
    • In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants
    • Bachelder EM, Beaudette TT, Broaders KE et al. In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants. Mol. Pharm. 7(3), 826-835 (2010).
    • (2010) Mol. Pharm. , vol.7 , Issue.3 , pp. 826-835
    • Bachelder, E.M.1    Beaudette, T.T.2    Broaders, K.E.3
  • 11
    • 0017744558 scopus 로고
    • Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation
    • Schorlemmer HU, Bitter-Suermann D, Allison AC. Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. Immunology 32(6), 929-940 (1977). (Pubitemid 8120584)
    • (1977) Immunology , vol.32 , Issue.6 , pp. 929-940
    • Schorlemmer, H.U.1    Bitter Suermann, D.2    Allison, A.C.3
  • 12
  • 13
    • 32944463876 scopus 로고    scopus 로고
    • Yeast zymosan a stimulus for TLR2 and dectin-1 induces regulatory antigen-presenting cells and immunological tolerance
    • Dillon S, Agrawal S, Banerjee K et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116(4), 916-928 (2006).
    • (2006) J. Clin. Invest. , vol.116 , Issue.4 , pp. 916-928
    • Dillon, S.1    Agrawal, S.2    Banerjee, K.3
  • 14
    • 0025084832 scopus 로고
    • Nonspecific resistance-enhancing activity of zymosan in experimental bacterial infections
    • Emod J, Joo I. Nonspecific resistance-enhancing activity of zymosan in experimental bacterial infections. Acta. Microbiol. Hung. 37(2), 187-192 (1990). (Pubitemid 20373564)
    • (1990) Acta Microbiologica Hungarica , vol.37 , Issue.2 , pp. 187-192
    • Emod, J.1    Joo, I.2
  • 15
    • 0021809035 scopus 로고
    • Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear β-1,3-D-glucan and other immunomodulators in murine cells
    • Morikawa K, Takeda R, Yamazaki M, Mizuno D. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear b-1,3-d-glucan and other immunomodulators in murine cells. Cancer Res. 45(4), 1496-1501 (1985). (Pubitemid 15079093)
    • (1985) Cancer Research , vol.45 , Issue.4 , pp. 1496-1501
    • Morikawa, K.1    Takeda, R.2    Yamazaki, M.3    Mizuno, D.4
  • 17
    • 75449106817 scopus 로고    scopus 로고
    • Zymosan enhances the mucosal adjuvant activity of poly I:C in a nasal influenza vaccine
    • Ainai A, Ichinohe T, Tamura S et al. Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine. J. Med. Virol. 82(3), 476-484 (2010).
    • (2010) J. Med. Virol. , vol.82 , Issue.3 , pp. 476-484
    • Ainai, A.1    Ichinohe, T.2    Tamura, S.3
  • 19
    • 68949092245 scopus 로고    scopus 로고
    • Fungal zymosan and mannan activate the cryopyrin inflammasome
    • Lamkanfi M, Malireddi RK, Kanneganti TD. Fungal zymosan and mannan activate the cryopyrin inflammasome. J. Biol. Chem. 284(31), 20574-20581 (2009).
    • (2009) J. Biol. Chem. , vol.284 , Issue.31 , pp. 20574-20581
    • Lamkanfi, M.1    Malireddi, R.K.2    Kanneganti, T.D.3
  • 20
    • 33745242490 scopus 로고    scopus 로고
    • β-Glucan derived from zymosan acts as an adjuvant for collagen-induced arthritis
    • Hida S, Nagi-Miura N, Adachi Y, Ohno N. b-glucan derived from zymosan acts as an adjuvant for collagen-induced arthritis. Microbiol. Immunol. 50(6), 453-461 (2006). (Pubitemid 43927234)
    • (2006) Microbiology and Immunology , vol.50 , Issue.6 , pp. 453-461
    • Hida, S.1    Nagi-Miura, N.2    Adachi, Y.3    Ohno, N.4
  • 21
    • 0026781218 scopus 로고
    • Stimulation of microbicidal host defence mechanisms against aerosol influenza virus infection by lentinan
    • Irinoda K, Masihi KN, Chihara G, Kaneko Y, Katori T. Stimulation of microbicidal host defence mechanisms against aerosol influenza virus infection by lentinan. Int. J. Immunopharmacol. 14(6), 971-977 (1992).
    • (1992) Int. J. Immunopharmacol. , vol.14 , Issue.6 , pp. 971-977
    • Irinoda, K.1    Masihi, K.N.2    Chihara, G.3    Kaneko, Y.4    Katori, T.5
  • 22
    • 0023690361 scopus 로고
    • Regression induced by lentinan of peritoneal carcinomatoses in a model of colon cancer in rat
    • Jeannin JF, Lagadec P, Pelletier H et al. Regression induced by lentinan, of peritoneal carcinomatoses in a model of colon cancer in rat. Int. J. Immunopharmacol. 10(7), 855-861 (1988).
    • (1988) Int. J. Immunopharmacol. , vol.10 , Issue.7 , pp. 855-861
    • Jeannin, J.F.1    Lagadec, P.2    Pelletier, H.3
  • 23
    • 0023505484 scopus 로고
    • Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: An overview
    • Chihara G, Hamuro J, Maeda YY et al. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview. Cancer Detect. Prev. Suppl. 1, 423-443 (1987).
    • (1987) Cancer Detect. Prev. Suppl. , vol.1 , pp. 423-443
    • Chihara, G.1    Hamuro, J.2    Maeda, Y.Y.3
  • 24
    • 13844294158 scopus 로고    scopus 로고
    • Combined immunomodulating effects of BCG and Lentinan after intranasal application in guinea pigs
    • DOI 10.1016/j.intimp.2004.12.008
    • Drandarska I, Kussovski V, Nikolaeva S, Markova N. Combined immunomodulating effects of BCG and Lentinan after intranasal application in guinea pigs. Int. Immunopharmacol. 5(4), 795-803 (2005). (Pubitemid 40248333)
    • (2005) International Immunopharmacology , vol.5 , Issue.4 , pp. 795-803
    • Drandarska, I.1    Kussovski, V.2    Nikolaeva, S.3    Markova, N.4
  • 25
    • 42249098141 scopus 로고    scopus 로고
    • Study on effect of lentinan in enhancing anti-tumor action of dendritic cytoma vaccine and its mechanism
    • Wang J, Zhou ZD, Xia DJ. Study on effect of lentinan in enhancing anti-tumor action of dendritic cytoma vaccine and its mechanism. Zhongguo Zhong Xi Yi Jie He Za Zhi 27(1), 60-64 (2007).
    • (2007) Zhongguo Zhong Xi Yi Jie He Za Zhi , vol.27 , Issue.1 , pp. 60-64
    • Wang, J.1    Zhou, Z.D.2    Xia, D.J.3
  • 26
    • 0024466158 scopus 로고
    • Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: A flow cytometric study
    • Abel G, Szollosi J, Chihara G, Fachet J. Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: a flow cytometric study. Int. J. Immunopharmacol. 11(6), 615-621 (1989). (Pubitemid 19239435)
    • (1989) International Journal of Immunopharmacology , vol.11 , Issue.6 , pp. 615-621
    • Abel, G.1    Szollosi, J.2    Chihara, G.3    Fachet, J.4
  • 27
    • 58149507765 scopus 로고    scopus 로고
    • Sulfated modification can enhance the adjuvanticity of lentinan and improve the immune effect of ND vaccine
    • Guo Z, Hu Y, Wang D et al. Sulfated modification can enhance the adjuvanticity of lentinan and improve the immune effect of ND vaccine. Vaccine 27(5), 660-665 (2009).
    • (2009) Vaccine , vol.27 , Issue.5 , pp. 660-665
    • Guo, Z.1    Hu, Y.2    Wang, D.3
  • 28
    • 34247539566 scopus 로고    scopus 로고
    • Specific immune response to HBsAg is enhanced by -βglucan oligosaccharide containing an α-1→3-linked bond and biased towards M2/Th2
    • Dong SF, Chen JM, Zhang Wet al. Specific immune response to HBsAg is enhanced by -βglucan oligosaccharide containing an a-(1→3)-linked bond and biased towards M2/Th2. Int. Immunopharmacol. 7(6), 725-733 (2007).
    • (2007) Int. Immunopharmacol. , vol.7 , Issue.6 , pp. 725-733
    • Dong, S.F.1    Chen, J.M.2    Zhang Wet3
  • 29
    • 0017225361 scopus 로고
    • In vivo and in vitro macrophage activation by systemic adjuvants
    • Bruley-Rosset M, Florentin I, Mathe G. In vivo and in vitro macrophage activation by systemic adjuvants. Agents Actions 6(1-3), 251-255 (1976).
    • (1976) Agents Actions , vol.6 , Issue.1-3 , pp. 251-255
    • Bruley-Rosset, M.1    Florentin, I.2    Mathe, G.3
  • 30
    • 77954550824 scopus 로고    scopus 로고
    • + T cells immune response induced by a DNA vaccine encoding hepatitis B virus core antigen
    • 10.1155/2010/645213 Epub ahead of print
    • Wang J, Dong S, Liu C et al. -βGlucan oligosaccharide enhances CD8(+) T cells immune response induced by a DNA vaccine encoding hepatitis B virus core antigen. J. Biomed. Biotechnol. DOI: 10.1155/2010/645213 (2010) (Epub ahead of print).
    • (2010) J. Biomed. Biotechnol.
    • Wang, J.1    Dong, S.2    Liu, C.3
  • 32
    • 65449166078 scopus 로고    scopus 로고
    • Distinct patterns of dendritic cell cytokine release stimulated by fungal -βglucans and Toll-like receptor agonists
    • Huang H, Ostroff GR, Lee CK, Wang JP, Specht CA, Levitz SM. Distinct patterns of dendritic cell cytokine release stimulated by fungal -βglucans and Toll-like receptor agonists. Infect. Immun. 77(5), 1774-1781 (2009).
    • (2009) Infect. Immun. , vol.77 , Issue.5 , pp. 1774-1781
    • Huang, H.1    Ostroff, G.R.2    Lee, C.K.3    Wang, J.P.4    Specht, C.A.5    Levitz, S.M.6
  • 33
    • 79952136886 scopus 로고    scopus 로고
    • Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded -βglucan particles
    • pii
    • Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM. Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded -βglucan particles. MBio 1(3), e00164-e00110, pii (2010).
    • (2010) MBio , vol.1 , Issue.3
    • Huang, H.1    Ostroff, G.R.2    Lee, C.K.3    Specht, C.A.4    Levitz, S.M.5
  • 34
    • 0022446293 scopus 로고
    • Anti-complementary action of polymorphic 'solubility forms' of particulate inulin
    • DOI 10.1016/0161-5890(86)90075-1
    • Cooper PD, Carter M. Anti-complementary action of polymorphic 'solubility forms' of particulate inulin. Mol. Immunol. 23(8), 895-901 (1986). (Pubitemid 16057598)
    • (1986) Molecular Immunology , vol.23 , Issue.8 , pp. 895-901
    • Cooper, P.D.1    Carter, M.2
  • 35
    • 0024206749 scopus 로고
    • The adjuvanticity of g inulin
    • Cooper PD, Steele EJ. The adjuvanticity of g inulin. Immunol. Cell. Biol. 66 ( Pt 5-6), 345-352 (1988).
    • (1988) Immunol. Cell. Biol. , vol.66 , Issue.5-6 , pp. 345-352
    • Cooper, P.D.1    Steele, E.J.2
  • 36
    • 0022458219 scopus 로고
    • The anti-melanoma activity of inulin in mice
    • DOI 10.1016/0161-5890(86)90076-3
    • Cooper PD, Carter M. The anti-melanoma activity of inulin in mice. Mol. Immunol. 23(8), 903-908 (1986). (Pubitemid 16057599)
    • (1986) Molecular Immunology , vol.23 , Issue.8 , pp. 903-908
    • Cooper, P.D.1    Carter, M.2
  • 37
    • 33846192034 scopus 로고    scopus 로고
    • Potentiation of photodynamic therapy of cancer by complement: The effect of γ-inulin
    • DOI 10.1038/sj.bjc.6603508, PII 6603508
    • Korbelik M, Cooper PD. Potentiation of photodynamic therapy of cancer by complement: the effect of g-inulin. Br. J. Cancer. 96(1), 67-72 (2007). (Pubitemid 46094641)
    • (2007) British Journal of Cancer , vol.96 , Issue.1 , pp. 67-72
    • Korbelik, M.1    Cooper, P.D.2
  • 38
    • 0025758163 scopus 로고
    • Algammulin a new vaccine adjuvant comprising g inulin particles containing alum: Preparation and in vitro properties
    • Cooper PD, Steele EJ. Algammulin, a new vaccine adjuvant comprising g inulin particles containing alum: preparation and in vitro properties. Vaccine 9(5), 351-357 (1991).
    • (1991) Vaccine , vol.9 , Issue.5 , pp. 351-357
    • Cooper, P.D.1    Steele, E.J.2
  • 39
    • 0029176545 scopus 로고
    • Vaccine adjuvants based on g inulin
    • Cooper PD. Vaccine adjuvants based on g inulin. Pharm. Biotechnol. 6, 559-580 (1995).
    • (1995) Pharm. Biotechnol. , vol.6 , pp. 559-580
    • Cooper, P.D.1
  • 40
    • 33645218007 scopus 로고    scopus 로고
    • Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity
    • Petrovsky N. Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity. Vaccine 24(Suppl. 2), 26-29 (2006).
    • (2006) Vaccine , vol.24 , Issue.2 , pp. 26-29
    • Petrovsky, N.1
  • 41
    • 9444239833 scopus 로고    scopus 로고
    • Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses
    • DOI 10.1111/j.1440-1711.2004.01290.x
    • Silva DG, Cooper PD, Petrovsky N. Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses. Immunol. Cell. Biol. 82(6), 611-616 (2004). (Pubitemid 39563962)
    • (2004) Immunology and Cell Biology , vol.82 , Issue.6 , pp. 611-616
    • Silva, D.G.1    Cooper, P.D.2    Petrovsky, N.3
  • 42
    • 0026022793 scopus 로고
    • Algammulin g inulin/alum hybrid adjuvant has greater adjuvanticity than alum for hepatitis B surface antigen in mice
    • Cooper PD, Turner R, McGovern J. Algammulin (g inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in mice. Immunol. Lett. 27(2), 131-134 (1991).
    • (1991) Immunol. Lett. , vol.27 , Issue.2 , pp. 131-134
    • Cooper, P.D.1    Turner, R.2    McGovern, J.3
  • 44
    • 79955100977 scopus 로고    scopus 로고
    • D inulin: A novel immunologically-active stable packing structure comprising -βd-2→1 polyfructo-furanosyl α-d glucose polymers
    • In Press
    • Cooper PD, Petrovsky N. d inulin: a novel, immunologically-active, stable packing structure comprising -βd-[2→1] poly(fructo-furanosyl) α-d glucose polymers. Glycobiology (2010) (In Press).
    • (2010) Glycobiology
    • Cooper, P.D.1    Petrovsky, N.2
  • 45
    • 77952717965 scopus 로고    scopus 로고
    • An inactivated vero cell-grown Japanese encephalitis vaccine formulated with advax a novel inulin-based adjuvant induces protective neutralizing antibody against homologous and heterologous flaviviruses
    • Lobigs M, Pavy M, Hall RA et al. An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses. J. Gen. Virol. 91(Pt 6), 1407-1417 (2010).
    • (2010) J. Gen. Virol. , vol.91 , Issue.6 , pp. 1407-1417
    • Lobigs, M.1    Pavy, M.2    Hall, R.A.3
  • 46
    • 78651250984 scopus 로고    scopus 로고
    • Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
    • Cristillo AD, Ferrari MG, Hudacik L et al. Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations. J. Gen. Virol. 92(Pt 1), 128-140 (2011).
    • (2011) J. Gen. Virol. , vol.92 , Issue.1 , pp. 128-140
    • Cristillo, A.D.1    Ferrari, M.G.2    Hudacik, L.3
  • 47
    • 40549113071 scopus 로고    scopus 로고
    • Freeing vaccine adjuvants from dangerous immunological dogma
    • DOI 10.1586/14760584.7.1.7
    • Petrovsky N. Freeing vaccine adjuvants from dangerous immunological dogma. Expert Rev. Vaccines 7(1), 7-10 (2008). (Pubitemid 351359053)
    • (2008) Expert Review of Vaccines , vol.7 , Issue.1 , pp. 7-10
    • Petrovsky, N.1
  • 48
    • 70350490533 scopus 로고    scopus 로고
    • Humoral pattern recognition molecules: Mannan-binding lectin and ficolins
    • Thiel S, Gadjeva M. Humoral pattern recognition molecules: mannan-binding lectin and ficolins. Adv. Exp. Med. Biol. 653, 58-73 (2009).
    • (2009) Adv. Exp. Med. Biol. , vol.653 , pp. 58-73
    • Thiel, S.1    Gadjeva, M.2
  • 50
    • 33745218281 scopus 로고    scopus 로고
    • Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells
    • Sheng KC, Pouniotis DS, Wright MD et al. Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells. Immunology 118(3), 372-383 (2006).
    • (2006) Immunology , vol.118 , Issue.3 , pp. 372-383
    • Sheng, K.C.1    Pouniotis, D.S.2    Wright, M.D.3
  • 52
    • 0037081476 scopus 로고    scopus 로고
    • Oxidised mannan as a novel adjuvant inducing mucosal IgA production
    • DOI 10.1016/S0264-410X(01)00456-X, PII S0264410X0100456X
    • Stambas J, Pietersz G, McKenzie I, Cheers C. Oxidised mannan as a novel adjuvant inducing mucosal IgA production. Vaccine 20(7-8), 1068-1078 (2002). (Pubitemid 34135942)
    • (2002) Vaccine , vol.20 , Issue.7-8 , pp. 1068-1078
    • Stambas, J.1    Pietersz, G.2    McKenzie, I.3    Cheers, C.4
  • 53
    • 70449339864 scopus 로고    scopus 로고
    • Altered peptide ligands of myelin basic protein MBP87-99 conjugated to reduced mannan modulate immune responses in mice
    • Katsara M, Yuriev E, Ramsland PA et al. Altered peptide ligands of myelin basic protein (MBP87-99) conjugated to reduced mannan modulate immune responses in mice. Immunology 128(4), 521-533 (2009).
    • (2009) Immunology , vol.128 , Issue.4 , pp. 521-533
    • Katsara, M.1    Yuriev, E.2    Ramsland, P.A.3
  • 54
    • 54149093133 scopus 로고    scopus 로고
    • Mannan-Ab28 conjugate prevents Ab-plaque deposition but increases microhemorrhages in the brains of vaccinated Tg2576 APPsw mice
    • Petrushina I, Ghochikyan A, Mkrtichyan M et al. Mannan-Ab28 conjugate prevents Ab-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice. J. Neuroinflammation 5, 42 (2008).
    • (2008) J. Neuroinflammation , vol.5 , pp. 42
    • Petrushina, I.1    Ghochikyan, A.2    Mkrtichyan, M.3
  • 55
    • 0034048871 scopus 로고    scopus 로고
    • Aloe polymannose enhances anti-coxsackievirus antibody titres in mice
    • DOI 10.1002/1099-1573(200006)14:4<261::AID-PTR579>3.0.CO;2-A
    • Gauntt CJ, Wood HJ, McDaniel HR, McAnalley BH. Aloe polymannose enhances anti-coxsackievirus antibody titres in mice. Phytother. Res. 14(4), 261-266 (2000). (Pubitemid 30410054)
    • (2000) Phytotherapy Research , vol.14 , Issue.4 , pp. 261-266
    • Gauntt, C.J.1    Wood, H.J.2    McDaniel, H.R.3    McAnalley, B.H.4
  • 56
    • 0033995526 scopus 로고    scopus 로고
    • Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes
    • Kawakami S, Sato A, Nishikawa M, Yamashita F, Hashida M. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther. 7(4), 292-299 (2000). (Pubitemid 30119732)
    • (2000) Gene Therapy , vol.7 , Issue.4 , pp. 292-299
    • Kawakami, S.1    Sato, A.2    Nishikawa, M.3    Yamashita, F.4    Hashida, M.5
  • 57
    • 0030823347 scopus 로고    scopus 로고
    • HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti- interferon-γ antibody
    • Toda S, Ishii N, Okada E et al. HIV-1- specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-g antibody. Immunology 92(1), 111-117 (1997). (Pubitemid 27380889)
    • (1997) Immunology , vol.92 , Issue.1 , pp. 111-117
    • Toda, S.1    Ishii, N.2    Okada, E.3    Kusakabe, K.-I.4    Arai, H.5    Hamajima, K.6    Gorai, I.7    Nishioka, K.8    Okuda, K.9
  • 58
    • 34247471316 scopus 로고    scopus 로고
    • Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes
    • DOI 10.1016/j.biomaterials.2007.03.028, PII S0142961207002670
    • Lu Y, Kawakami S, Yamashita F, Hashida M. Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes. Biomaterials 28(21), 3255-3262 (2007). (Pubitemid 46654220)
    • (2007) Biomaterials , vol.28 , Issue.21 , pp. 3255-3262
    • Lu, Y.1    Kawakami, S.2    Yamashita, F.3    Hashida, M.4
  • 59
    • 24744448887 scopus 로고    scopus 로고
    • Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against Hepatitis B
    • DOI 10.1016/j.imlet.2005.04.002, PII S0165247805000994
    • Jain S, Singh P, Mishra V, Vyas SP. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol. Lett. 101(1), 41-49 (2005). (Pubitemid 41297497)
    • (2005) Immunology Letters , vol.101 , Issue.1 , pp. 41-49
    • Jain, S.1    Singh, P.2    Mishra, V.3    Vyas, S.P.4
  • 60
    • 25844510763 scopus 로고    scopus 로고
    • Mannosylated niosomes as carrier adjuvant system for topical immunization
    • DOI 10.1211/jpp.57.9.0012
    • Jain S, Vyas SP. Mannosylated niosomes as carrier adjuvant system for topical immunization. J. Pharm. Pharmacol. 57(9), 1177-1184 (2005). (Pubitemid 41391776)
    • (2005) Journal of Pharmacy and Pharmacology , vol.57 , Issue.9 , pp. 1177-1184
    • Jain, S.1    Vyas, S.P.2
  • 62
    • 0030834536 scopus 로고    scopus 로고
    • A comparison of antibody responses to: Veterinary vaccine antigens potentiated by different adjuvants
    • DOI 10.1016/S0264-410X(97)00136-9, PII S0264410X97001369
    • Usinger WR. A comparison of antibody responses to veterinary vaccine antigens potentiated by different adjuvants. Vaccine 15(17-18), 1902-1907 (1997). (Pubitemid 27504686)
    • (1997) Vaccine , vol.15 , Issue.17-18 , pp. 1902-1907
    • Usinger, W.R.1
  • 63
    • 0026717420 scopus 로고
    • Antigen dependent adjuvant activity of a polydispersed -β1 4-linked acetylated mannan acemannan
    • Chinnah AD, Baig MA, Tizard IR, Kemp MC. Antigen dependent adjuvant activity of a polydispersed b-(1,4)-linked acetylated mannan (acemannan).Vaccine 10(8), 551-557 (1992).
    • (1992) Vaccine , vol.10 , Issue.8 , pp. 551-557
    • Chinnah, A.D.1    Baig, M.A.2    Tizard, I.R.3    Kemp, M.C.4
  • 64
    • 67650550954 scopus 로고    scopus 로고
    • Chitosan-based systems for the delivery of vaccine antigens
    • Arca HC, Gunbeyaz M, Senel S. Chitosan-based systems for the delivery of vaccine antigens. Expert Rev. Vaccines 8(7), 937-953 (2009).
    • (2009) Expert Rev. Vaccines , vol.8 , Issue.7 , pp. 937-953
    • Arca, H.C.1    Gunbeyaz, M.2    Senel, S.3
  • 65
    • 33745855443 scopus 로고    scopus 로고
    • Phagocytosis of N-acetyl-d-glucosamine particles, a Th1 adjuvant, by RAW 264.7 cells results in MAPK activation and TNF-α, but not IL-10, production
    • DOI 10.1016/j.cellimm.2006.04.003, PII S0008874906000700
    • Nishiyama A, Tsuji S, Yamashita M, Henriksen RA, Myrvik QN, Shibata Y. Phagocytosis of N-acetyl-d-glucosamine particles, a Th1 adjuvant, by RAW264.7 cells results in MAPK activation and TNF-a, but not IL-10, production. Cell. Immunol. 239(2), 103-112 (2006). (Pubitemid 44037541)
    • (2006) Cellular Immunology , vol.239 , Issue.2 , pp. 103-112
    • Nishiyama, A.1    Tsuji, S.2    Yamashita, M.3    Henriksen, R.A.4    Myrvik, Q.N.5    Shibata, Y.6
  • 66
    • 60049091313 scopus 로고    scopus 로고
    • Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally
    • Ghendon Y, Markushin S, Vasiliev Y et al. Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally. J. Med. Virol. 81(3), 494-506 (2009).
    • (2009) J. Med. Virol. , vol.81 , Issue.3 , pp. 494-506
    • Ghendon, Y.1    Markushin, S.2    Vasiliev, Y.3
  • 67
    • 77956386955 scopus 로고    scopus 로고
    • Comparison of adjuvant efficacy of chitosan and aluminum hydroxide for intraperitoneally administered inactivated influenza H5N1 vaccine
    • Chang H, Li X, Teng Y et al. Comparison of adjuvant efficacy of chitosan and aluminum hydroxide for intraperitoneally administered inactivated influenza H5N1 vaccine. DNA Cell. Biol. 29(9), 563-568 (2010).
    • (2010) DNA Cell. Biol. , vol.29 , Issue.9 , pp. 563-568
    • Chang, H.1    Li, X.2    Teng, Y.3
  • 68
    • 77649186195 scopus 로고    scopus 로고
    • Chitosan-based nanoparticles for improving immunization against hepatitis B infection
    • Prego C, Paolicelli P, Diaz B et al. Chitosan-based nanoparticles for improving immunization against hepatitis B infection. Vaccine 28(14), 2607-2614 (2010).
    • (2010) Vaccine , vol.28 , Issue.14 , pp. 2607-2614
    • Prego, C.1    Paolicelli, P.2    Diaz, B.3
  • 69
    • 0030839517 scopus 로고    scopus 로고
    • N-Trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: In vitro evaluation in intestinal epithelial cells (Caco-2)
    • DOI 10.1023/A:1012106907708
    • Kotze AF, Luessen HL, de Leeuw BJ, de Boer BG, Verhoef JC, Junginger HE. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).Pharm. Res. 14(9), 1197-1202 (1997). (Pubitemid 27432543)
    • (1997) Pharmaceutical Research , vol.14 , Issue.9 , pp. 1197-1202
    • Kotze, A.F.1    Luessen, H.L.2    De Leeuw, B.J.3    De Boer, B.G.4    Verhoef, J.C.5    Junginger, H.E.6
  • 70
    • 0242317689 scopus 로고    scopus 로고
    • The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines
    • DOI 10.1016/S0264-410X(03)00305-0
    • Baudner BC, Giuliani MM, Verhoef JC, Rappuoli R, Junginger HE, Giudice GD. The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines. Vaccine 21(25-26), 3837-3844 (2003). (Pubitemid 37338211)
    • (2003) Vaccine , vol.21 , Issue.25-26 , pp. 3837-3844
    • Baudner, B.C.1    Giuliani, M.M.2    Verhoef, J.C.3    Rappuoli, R.4    Junginger, H.E.5    Del Giudice, G.6
  • 71
    • 43249088985 scopus 로고    scopus 로고
    • Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
    • Borges O, Cordeiro-da-Silva A, Tavares J et al. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles. Eur. J. Pharm. Biopharm. 69(2), 405-416 (2008).
    • (2008) Eur. J. Pharm. Biopharm. , vol.69 , Issue.2 , pp. 405-416
    • Borges, O.1    Cordeiro-Da-Silva, A.2    Tavares, J.3
  • 72
    • 2342621524 scopus 로고    scopus 로고
    • Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1
    • DOI 10.1016/j.vaccine.2003.11.011, PII S0264410X0300776X
    • Gogev S, de Fays K, Versali MF, Gautier S, Thiry E. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1. Vaccine 22(15-16), 1946-1953 (2004). (Pubitemid 38581064)
    • (2004) Vaccine , vol.22 , Issue.15-16 , pp. 1946-1953
    • Gogev, S.1    De Fays, K.2    Versali, M.-F.3    Gautier, S.4    Thiry, E.5
  • 73
    • 40849120029 scopus 로고    scopus 로고
    • Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B
    • Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Int. J. Pharm. 354(1-2), 235-241 (2008).
    • (2008) Int. J. Pharm. , vol.354 , Issue.1-2 , pp. 235-241
    • Khatri, K.1    Goyal, A.K.2    Gupta, P.N.3    Mishra, N.4    Vyas, S.P.5
  • 74
    • 70349998153 scopus 로고    scopus 로고
    • TMC-MCC N-trimethyl chitosan-mono-N-carboxymethyl chitosan nanocomplexes for mucosal delivery of vaccines
    • Sayin B, Somavarapu S, Li XW, Sesardic D, Senel S, Alpar OH. TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines. Eur. J. Pharm. Sci. 38(4), 362-369 (2009).
    • (2009) Eur. J. Pharm. Sci. , vol.38 , Issue.4 , pp. 362-369
    • Sayin, B.1    Somavarapu, S.2    Li, X.W.3    Sesardic, D.4    Senel, S.5    Alpar, O.H.6
  • 75
    • 65849217248 scopus 로고    scopus 로고
    • Cellular immunity induced by H. pylori vaccine with chitosan as adjuvant
    • Gong YF, Xie Y, Zhou NJ et al. Cellular immunity induced by H. pylori vaccine with chitosan as adjuvant. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23(7), 595-599 (2007).
    • (2007) Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi , vol.23 , Issue.7 , pp. 595-599
    • Gong, Y.F.1    Xie, Y.2    Zhou, N.J.3
  • 76
    • 0034833470 scopus 로고    scopus 로고
    • Th1 adjuvant N-acetyl-D-glucosamine polymer up-regulates th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10-knockout and wild-type mice
    • DOI 10.1128/IAI.69.10.6123-6130.2001
    • Shibata Y, Honda I, Justice JP, Van Scott MR, Nakamura RM, Myrvik QN. Th1 adjuvant N-acetyl-d-glucosamine polymer up-regulates Th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10-knockout and wild-type mice. Infect. Immun. 69(10), 6123-6130 (2001). (Pubitemid 32885173)
    • (2001) Infection and Immunity , vol.69 , Issue.10 , pp. 6123-6130
    • Shibata, Y.1    Honda, I.2    Justice, J.P.3    Van Scott, M.R.4    Nakamura, R.M.5    Myrvik, Q.N.6
  • 77
    • 0034142181 scopus 로고    scopus 로고
    • Oral administration of chitin down-regulates serum IgE levels and lung eosinophilia in the allergic mouse
    • Shibata Y, Foster LA, Bradfield JF, Myrvik QN. Oral administration of chitin down-regulates serum IgE levels and lung eosinophilia in the allergic mouse. J. Immunol. 164(3), 1314-1321 (2000). (Pubitemid 30067244)
    • (2000) Journal of Immunology , vol.164 , Issue.3 , pp. 1314-1321
    • Shibata, Y.1    Foster, L.A.2    Bradfield, J.F.3    Myrvik, Q.N.4
  • 78
    • 70349201241 scopus 로고    scopus 로고
    • Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to mycobacterium tuberculosis HIV-1 and helicobacter pylori
    • Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. 10(10), 1081-1088 (2009).
    • (2009) Nat. Immunol. , vol.10 , Issue.10 , pp. 1081-1088
    • Gringhuis, S.I.1    Den Dunnen, J.2    Litjens, M.3    Van Der Vlist, M.4    Geijtenbeek, T.B.5
  • 79
    • 34548829647 scopus 로고    scopus 로고
    • Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan
    • DOI 10.1074/jbc.M702690200
    • Doz E, Rose S, Nigou J et al. Acylation determines the Toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1- independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J. Biol. Chem. 282(36), 26014-26025 (2007). (Pubitemid 47443801)
    • (2007) Journal of Biological Chemistry , vol.282 , Issue.36 , pp. 26014-26025
    • Doz, E.1    Rose, S.2    Nigou, J.3    Gilleron, M.4    Puzo, G.5    Erard, F.6    Ryffel, B.7    Quesniaux, V.F.J.8
  • 80
    • 34548829647 scopus 로고    scopus 로고
    • Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan
    • DOI 10.1074/jbc.M702690200
    • Doz E, Rose S, Nigou J et al. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1- independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J. Biol. Chem. 282(36), 26014-26025 (2007). (Pubitemid 47443801)
    • (2007) Journal of Biological Chemistry , vol.282 , Issue.36 , pp. 26014-26025
    • Doz, E.1    Rose, S.2    Nigou, J.3    Gilleron, M.4    Puzo, G.5    Erard, F.6    Ryffel, B.7    Quesniaux, V.F.J.8
  • 82
    • 0017030170 scopus 로고
    • Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-l-alanyl-d- isoglutamine
    • Yamamura Y, Azuma I, Sugimura K, Yamawaki M, Uemiya M. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-l-alanyl-d-isoglutamine. Gann 67(6), 867-877 (1976).
    • (1976) Gann. , vol.67 , Issue.6 , pp. 867-877
    • Yamamura, Y.1    Azuma, I.2    Sugimura, K.3    Yamawaki, M.4    Uemiya, M.5
  • 83
    • 12444259829 scopus 로고    scopus 로고
    • Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner respectively in human monocytic cells in culture
    • Uehara A, Yang S, Fujimoto Y et al. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell. Microbiol. 7(1), 53-61 (2005).
    • (2005) Cell. Microbiol. , vol.7 , Issue.1 , pp. 53-61
    • Uehara, A.1    Yang, S.2    Fujimoto, Y.3
  • 84
    • 33750557881 scopus 로고    scopus 로고
    • Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling
    • DOI 10.2174/138161206778743510
    • Takada H, Uehara A. Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling. Curr. Pharm. Des. 12(32), 4163-4172 (2006). (Pubitemid 44669745)
    • (2006) Current Pharmaceutical Design , vol.12 , Issue.32 , pp. 4163-4172
    • Takada, H.1    Uehara, A.2
  • 85
    • 0019440936 scopus 로고
    • Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D- isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs
    • Azuma I, Okumura H, Saiki I et al. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-l-alanyl-d-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-l-tyrosine in guinea pigs. Infect. Immun. 33(3), 834-839 (1981). (Pubitemid 11051079)
    • (1981) Infection and Immunity , vol.33 , Issue.3 , pp. 834-839
    • Azuma, I.1    Okumura, H.2    Saiki, I.3
  • 86
    • 0027984259 scopus 로고
    • Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants
    • Valensi JP, Carlson JR, Van Nest GA. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J. Immunol. 153(9), 4029-4039 (1994).
    • (1994) J. Immunol. , vol.153 , Issue.9 , pp. 4029-4039
    • Valensi, J.P.1    Carlson, J.R.2    Van Nest, G.A.3
  • 87
    • 0028792511 scopus 로고
    • Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59
    • Ott G, Barchfeld GL, Van Nest G. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59. Vaccine 13(16), 1557-1562 (1995).
    • (1995) Vaccine , vol.13 , Issue.16 , pp. 1557-1562
    • Ott, G.1    Barchfeld, G.L.2    Van Nest, G.3
  • 88
    • 0025901039 scopus 로고
    • Phase I trial of ImmTher a new liposome-incorporated lipophilic disaccharide tripeptide
    • Vosika GJ, Cornelius DA, Gilbert CWet al. Phase I trial of ImmTher, a new liposome-incorporated lipophilic disaccharide tripeptide. J. Immunother. 10(4), 256-266 (1991).
    • (1991) J. Immunother. , vol.10 , Issue.4 , pp. 256-266
    • Vosika, G.J.1    Cornelius, D.A.2    Gilbert, C.W.3
  • 89
    • 0025395754 scopus 로고
    • Immunologic and toxicologic study of disaccharide tripeptide glycerol dipalmitoyl: A new lipophilic immunomodulator
    • Vosika GJ, Cornelius DA, Bennek JA, Sadlik JR, Gilbert CW. Immunologic and toxicologic study of disaccharide tripeptide glycerol dipalmitoyl: a new lipophilic immunomodulator. Mol. Biother. 2(1), 50-56 (1990).
    • (1990) Mol. Biother. , vol.2 , Issue.1 , pp. 50-56
    • Vosika, G.J.1    Cornelius, D.A.2    Bennek, J.A.3    Sadlik, J.R.4    Gilbert, C.W.5
  • 90
    • 7044260110 scopus 로고
    • Muramyl peptides as immunopharmacological response modifiers
    • Torrence PF Ed.Academic Press Inc. Orlando FL USA
    • Audibert F, Leclerc C, Chedid L. Muramyl peptides as immunopharmacological response modifiers. In:Biological Response Modifiers. Torrence PF (Ed.).Academic Press, Inc., Orlando, FL, USA, 307-337 (1985).
    • (1985) Biological Response Modifiers , pp. 307-337
    • Audibert, F.1    Leclerc, C.2    Chedid, L.3
  • 91
    • 0001862656 scopus 로고    scopus 로고
    • Effectivity of alternative adjuvants in comparison to freunds complete adjuvant
    • Schwarzkopf C, Thiele B. Effectivity of alternative adjuvants in comparison to freund's complete adjuvant. ALTEX 13(5), 22-25 (1996).
    • (1996) ALTEX , vol.13 , Issue.5 , pp. 22-25
    • Schwarzkopf, C.1    Thiele, B.2
  • 92
    • 0029129657 scopus 로고
    • Activation of protein kinase C by mycobacterial cord factor trehalose 6-monomycolate resulting in tumor necrosis factor-a release in mouse lung tissues
    • Sueoka E, Nishiwaki S, Okabe S et al. Activation of protein kinase C by mycobacterial cord factor, trehalose 6-monomycolate, resulting in tumor necrosis factor-a release in mouse lung tissues. Jpn J. Cancer Res. 86(8), 749-755 (1995).
    • (1995) Jpn J. Cancer Res. , vol.86 , Issue.8 , pp. 749-755
    • Sueoka, E.1    Nishiwaki, S.2    Okabe, S.3
  • 93
    • 0021033692 scopus 로고
    • Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection
    • DOI 10.1016/0192-0561(83)90015-2
    • Masihi KN, Brehmer W, Lange W, Ribi E. Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection. Int. J. Immunopharmacol. 5(5), 403-410 (1983). (Pubitemid 14239809)
    • (1983) International Journal of Immunopharmacology , vol.5 , Issue.5 , pp. 403-410
    • Masihi, K.N.1    Brehmer, W.2    Lange, W.3    Ribi, E.4
  • 94
    • 34247645972 scopus 로고    scopus 로고
    • Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice
    • DOI 10.1016/j.micpath.2007.02.006, PII S088240100700023X
    • Fujita Y, Okamoto Y, Uenishi Y, Sunagawa M, Uchiyama T, Yano I. Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice. Microb. Pathog. 43(1), 10-21 (2007). (Pubitemid 46678643)
    • (2007) Microbial Pathogenesis , vol.43 , Issue.1 , pp. 10-21
    • Fujita, Y.1    Okamoto, Y.2    Uenishi, Y.3    Sunagawa, M.4    Uchiyama, T.5    Yano, I.6
  • 95
    • 0032387991 scopus 로고    scopus 로고
    • Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine
    • DOI 10.1016/S0264-410X(98)00084-X, PII S0264410X9800084X
    • Koike Y, Yoo YC, Mitobe M et al. Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine. Vaccine 16(20), 1982-1989 (1998). (Pubitemid 28473946)
    • (1998) Vaccine , vol.16 , Issue.20 , pp. 1982-1989
    • Koike, Y.1    Yoo, Y.C.2    Mitobe, M.3    Oka, T.4    Okuma, K.5    Tono-Oka, S.6    Azuma, I.7
  • 96
    • 0016612654 scopus 로고
    • Biologically active components from mycobacterial cell walls IV protection of mice against aerosol infection with virulent mycobacterium tuberculosis
    • Ribi E, Meyer TJ, Azuma I, Parker R, Brehmer W. Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent Mycobacterium tuberculosis. Cell. Immunol. 16(1), 1-10 (1975).
    • (1975) Cell. Immunol. , vol.16 , Issue.1 , pp. 1-10
    • Ribi, E.1    Meyer, T.J.2    Azuma, I.3    Parker, R.4    Brehmer, W.5
  • 98
    • 0022544882 scopus 로고
    • Immunobiological activities of nontoxic lipid A: Enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects
    • DOI 10.1016/0192-0561(86)90116-5
    • Masihi KN, Lange W, Brehmer W, Ribi E. Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects. Int. J. Immunopharmacol. 8(3), 339-345 (1986). (Pubitemid 16063773)
    • (1986) International Journal of Immunopharmacology , vol.8 , Issue.3 , pp. 339-345
    • Masihi, K.N.1    Lange, W.2    Brehmer, W.3    Ribi, E.4
  • 99
    • 70450253086 scopus 로고    scopus 로고
    • Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A
    • Cekic C, Casella CR, Eaves CA, Matsuzawa A, Ichijo H, Mitchell TC. Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A. J. Biol. Chem. 284(46), 31982-31991 (2009).
    • (2009) J. Biol. Chem. , vol.284 , Issue.46 , pp. 31982-31991
    • Cekic, C.1    Casella, C.R.2    Eaves, C.A.3    Matsuzawa, A.4    Ichijo, H.5    Mitchell, T.C.6
  • 100
    • 49749105995 scopus 로고    scopus 로고
    • An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
    • Schiller JT, Castellsague X, Villa LL, Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine 26(Suppl. 10), K53-K61 (2008).
    • (2008) Vaccine , vol.26 , Issue.10
    • Schiller, J.T.1    Castellsague, X.2    Villa, L.L.3    Hildesheim, A.4
  • 102
    • 33846826420 scopus 로고    scopus 로고
    • Bioactive saponins with cancer related and immunomodulatory activity: Recent developments
    • Atta ur R (Ed.).Elsevier Amsterdam The Netherlands
    • Lacaille-Dubois MA. Bioactive saponins with cancer related and immunomodulatory activity: recent developments. In:Studies in Natural Products Chemistry. Atta ur R (Ed.).Elsevier, Amsterdam, The Netherlands, 209-246 (2005).
    • (2005) Studies in Natural Products Chemistry , pp. 209-246
    • Lacaille-Dubois, M.A.1
  • 104
    • 0041337005 scopus 로고    scopus 로고
    • Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system
    • DOI 10.1078/094471103322331421
    • Raphael TJ, Kuttan G. Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system. Phytomedicine 10(6-7), 483-489 (2003). (Pubitemid 37092670)
    • (2003) Phytomedicine , vol.10 , Issue.6-7 , pp. 483-489
    • Raphael, T.J.1    Kuttan, G.2
  • 105
    • 0029176755 scopus 로고
    • Structural and immunological characterization of the vaccine adjuvant QS-21
    • Kensil CR, Wu JY, Soltysik S. Structural and immunological characterization of the vaccine adjuvant QS-21. Pharm. Biotechnol. 6, 525-541 (1995).
    • (1995) Pharm. Biotechnol. , vol.6 , pp. 525-541
    • Kensil, C.R.1    Wu, J.Y.2    Soltysik, S.3
  • 107
    • 15044347193 scopus 로고    scopus 로고
    • + T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: Quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites
    • DOI 10.1016/j.vaccine.2004.10.044
    • + T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites. Vaccine 23(21), 2801-2812 (2005). (Pubitemid 40381274)
    • (2005) Vaccine , vol.23 , Issue.21 , pp. 2801-2812
    • Meraldi, V.1    Romero, J.F.2    Kensil, C.3    Corradin, G.4
  • 108
    • 33749561154 scopus 로고    scopus 로고
    • Saponins from Quillaja saponaria Molina: Isolation, characterization and ability to form Immuno Stimulatory Complexes (ISCOMs)
    • DOI 10.2174/156720106778559092
    • Pham HL, Ross BP, McGeary RP, Shaw PN, Hewavitharana AK, Davies NM. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).Curr. Drug Deliv. 3(4), 389-397 (2006). (Pubitemid 44534051)
    • (2006) Current Drug Delivery , vol.3 , Issue.4 , pp. 389-397
    • Pham, H.L.1    Ross, B.P.2    McGeary, R.P.3    Shaw, P.N.4    Hewavitharana, A.K.5    Davies, N.M.6
  • 109
    • 61349084783 scopus 로고    scopus 로고
    • Advances in saponin-based adjuvants
    • Sun HX, Xie Y, Ye YP. Advances in saponin-based adjuvants. Vaccine 27(12), 1787-1796 (2009).
    • (2009) Vaccine , vol.27 , Issue.12 , pp. 1787-1796
    • Sun, H.X.1    Xie, Y.2    Ye, Y.P.3
  • 111
    • 0141882443 scopus 로고    scopus 로고
    • Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100
    • DOI 10.1016/S0264-410X(03)00298-6
    • Marciani DJ, Reynolds RC, Pathak AK, Finley-Woodman K, May RD. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100. Vaccine 21(25-26), 3961-3971 (2003). (Pubitemid 37338224)
    • (2003) Vaccine , vol.21 , Issue.25-26 , pp. 3961-3971
    • Marciani, D.J.1    Reynolds, R.C.2    Pathak, A.K.3    Finley-Woodman, K.4    May, R.D.5
  • 112
    • 32544434934 scopus 로고    scopus 로고
    • Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2
    • DOI 10.1016/j.vaccine.2005.10.017, PII S0264410X05010522
    • Quenelle DC, Collins DJ, Marciani DJ, Kern ER. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2. Vaccine 24(10), 1515-1522 (2006). (Pubitemid 43238225)
    • (2006) Vaccine , vol.24 , Issue.10 , pp. 1515-1522
    • Quenelle, D.C.1    Collins, D.J.2    Marciani, D.J.3    Kern, E.R.4
  • 113
    • 53249115473 scopus 로고    scopus 로고
    • Effect of an immune enhancer GPI-0100 on vaccination with live attenuated herpes simplex virus HSV type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs
    • Quenelle DC, Collins DJ, Rice TL, Prichard MN, Marciani DJ, Kern ER. Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs. Antiviral Res. 80(2), 223-224 (2008).
    • (2008) Antiviral Res. , vol.80 , Issue.2 , pp. 223-224
    • Quenelle, D.C.1    Collins, D.J.2    Rice, T.L.3    Prichard, M.N.4    Marciani, D.J.5    Kern, E.R.6
  • 115
    • 68749105932 scopus 로고    scopus 로고
    • Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein C4BP
    • Rawal N, Rajagopalan R, Salvi VP. Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP).Mol. Immunol. 46(15), 2902-2910 (2009).
    • (2009) Mol. Immunol. , vol.46 , Issue.15 , pp. 2902-2910
    • Rawal, N.1    Rajagopalan, R.2    Salvi, V.P.3
  • 116
    • 0018611170 scopus 로고
    • Purification of a mannan from Candida albicans which activates serum complement
    • Ray TL, Hanson A, Ray LF, Wuepper KD. Purification of a mannan from Candida albicans which activates serum complement. J. Invest. Dermatol. 73(4), 269-274 (1979). (Pubitemid 10161226)
    • (1979) Journal of Investigative Dermatology , vol.73 , Issue.4 , pp. 269-274
    • Ray, T.L.1    Hanson, A.2    Ray, L.F.3    Wuepper, K.D.4
  • 117
    • 0023191243 scopus 로고
    • Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides - Studies on active components and structural requirements
    • Kawasaki A, Takada H, Kotani S et al. Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides-studies on active components and structural requirements. Microbiol. Immunol. 31(6), 551-569 (1987). (Pubitemid 17117231)
    • (1987) Microbiology and Immunology , vol.31 , Issue.6 , pp. 551-569
    • Kawasaki, A.1    Takada, H.2    Kotani, S.3
  • 119
    • 0025955352 scopus 로고
    • Modification of lymphocyte migration by mannans and phosphomannans different carbohydrate structures control entry of lymphocytes into spleen and lymph nodes
    • Weston SA, Parish CR. Modification of lymphocyte migration by mannans and phosphomannans. Different carbohydrate structures control entry of lymphocytes into spleen and lymph nodes. J. Immunol. 146(12), 4180-4186 (1991).
    • (1991) J. Immunol. , vol.146 , Issue.12 , pp. 4180-4186
    • Weston, S.A.1    Parish, C.R.2
  • 120
    • 0036630093 scopus 로고    scopus 로고
    • Leishmania major activates IL-1α expression in macrophages through a MyD88-dependent pathway
    • DOI 10.1016/S1286-4579(02)01596-4, PII S1286457902015964
    • Hawn TR, Ozinsky A, Underhill DM, Buckner FS, Akira S, Aderem A. Leishmania major activates IL-1 a expression in macrophages through a MyD88-dependent pathway. Microbes Infect. 4(8), 763-771 (2002). (Pubitemid 35247439)
    • (2002) Microbes and Infection , vol.4 , Issue.8 , pp. 763-771
    • Hawn, T.R.1    Ozinsky, A.2    Underhill, D.M.3    Buckner, F.S.4    Akira, S.5    Aderem, A.6
  • 121
    • 0037150482 scopus 로고    scopus 로고
    • QS-21 structure/function studies: Effect of acylation on adjuvant activity
    • DOI 10.1016/S0264-410X(02)00209-8, PII S0264410X02002098
    • Liu G, Anderson C, Scaltreto H, Barbon J, Kensil CR. QS-21 structure/function studies: effect of acylation on adjuvant activity. Vaccine 20(21-22), 2808-2815 (2002). (Pubitemid 34597141)
    • (2002) Vaccine , vol.20 , Issue.21-22 , pp. 2808-2815
    • Liu, G.1    Anderson, C.2    Scaltreto, H.3    Barbon, J.4    Kensil, C.R.5
  • 122
    • 52049115713 scopus 로고    scopus 로고
    • Synthesis of QS-21-xylose: Establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine
    • Deng K, Adams MM, Damani P, Livingston PO, Ragupathi G, Gin DY. Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine. Angew. Chem. Int. Ed. Engl. 47(34), 6395-6398 (2008).
    • (2008) Angew. Chem. Int. Ed. Engl. , vol.47 , Issue.34 , pp. 6395-6398
    • Deng, K.1    Adams, M.M.2    Damani, P.3    Livingston, P.O.4    Ragupathi, G.5    Gin, D.Y.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.